Abstract: Glucose is aubiquitous energy source for most living organisms.Its uptake activity closely reflects cellular metabolic demand in various physiopathological conditions.E xtensive efforts have been made to specifically image glucose uptake, such as with positron emission tomography,m agnetic resonance imaging,a nd fluorescence microscopy, but all have limitations.Anew platform to visualizeglucose uptake activity in live cells and tissues is presented that involves performing stimulated Raman scattering on an ovel glucose analogue labeled with asmall alkyne moiety.Cancer cells with differing metabolic activities can be distinguished. Heterogeneous uptake patterns are observed with clear cell-cell variations in tumor xenograft tissues,n euronal culture,a nd mouse brain tissues.Byoffering the distinct advantage of optical resolution but without the undesirable influence of fluorophores,t his method will facilitate the study of energy demands of living systems with subcellular resolution.
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Glucose is the primary energy source for virtually all living organisms,f rom bacteria to humans.A sah ydrophilic small molecule,t he uptake of glucose is mediated by cell surface transporters to pass through the otherwise impermeable hydrophobic plasma membrane,d uring which the ATPindependent facilitated diffusion down ag lucose concentration gradient is the major pathway.S ince the uptake of glucose is biologically regulated and closely correlated to awide range of metabolic transformations,several prominent techniques have been developed to selectively image glucose uptake activity.A mong them, radioactive tracers of glucose analogues (Figure 1a ,b) are widely applied in clinical positron emission tomography (PET) to image glucose uptake activity in vivo.A lthough these PET analogues cannot be metabolized like d-glucose in the glycolytic pathway and thus accumulate inside cells,t heir net flux across cell membrane still reflects the total exogenous cellular glucose use when imaged under steady-state conditions. [1] Indeed, imaging steady-state glucose uptake level has been shown by extensive PET studies to be ak ey diagnostic marker in many diseases. More recently,m agnetic resonance imaging (MRI) has achieved glucose imaging in tumors through chemical exchange saturation transfer and hyperpolarization of 13 Clabeled d-glucose. [2] Unfortunately,b oth PET and MRI techniques have limited spatial resolution, and cannot visualize glucose uptake in single cells.Glucose uptake and energy demands in many crucial physiological (for example,b rain activity) and pathological processes (for example,t umor development) are intrinsically heterogeneous at the cellular level.
[3] Hence,t ov isualize glucose uptake activity in single living cells is indispensable in evaluating the metabolic demand of individual cells and unveiling the underlying cell-to-cell variations.
To monitor glucose uptake with cellular resolution, fluorophore-conjugated glucose analogues have been developed for fluorescence microscopy.2 -[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-d-glucose (2-NBDG) (Figure 1c) , which is also ag lucose analogue that cannot be metabolized further in glycolysis,i so ne of the most popular probes and has been applied in av ariety of cell types. [4] However,c onjugation of glucose with fluorophores,w hich are mostly hydrophobic or charged, alters the hydrophilic property of natural glucose.Indeed, the water solubility of 2-NBDG is substantially reduced to about 10 mg mL À1 .M oreover, physical sizes of fluorophores are always larger than glucose itself,o wing to the requirement of extended conjugation for visible light absorption. Thus,m ost fluorescent glucose analogues,i ncluding 2-NBDG,e xhibit non-specific interactions and retentions in cells and tissues, [5] which would bias the true glucose distribution to varying degrees.
Herein we report an ew modality to visualize glucose uptake activity at the subcellular level by stimulated Raman (Figure 1b )y et avoids the use of radioactive isotopes and allows for subcellular optical imaging. Compared with fluorophores,the alkyne tag (C C) is physically much smaller and has been proven to be chemically inert and bioorthogonal in cells by numerous clickchemistry studies. [6] Thus,w ee xpect 3-OPG to not only preserve the hydrophilic nature of glucose but also prevent its non-specific interactions in cells and tissues.D etection-wise, the alkyne tag exhibits apronounced C Cstretching Raman peak (ca. 2100 cm À1 )i nt he cell-silent spectral region. [7] Very recently,alkyne tags have been coupled to SRS microscopy as apowerful vibrational label for metabolic imaging in live cells with high sensitivity,s pecificity,a nd biocompatibility. [8] Therefore,b yt argeting the unique vibrational signature of alkyne tags,S RS imaging of 3-OPG uptake could be av aluable method to study energy demands and metabolic status in living systems with subcellular resolution and minimal perturbation.
We first synthesized 3-OPG by conjugating ap ropargyl group to glucose 3' OH group (Figure 1d ). Briefly,c ommercially available 1,2:5,6-di-O-isopropylidene-a-d-glucofuranose 2 is reacted with propargyl bromide to selectively introduce the alkyne moiety onto the 3' position, which gives 3 in 90 %y ield. Deprotection of 3 in strong acids affords 3-OPG 1 with 96 %y ield. Comparing 3-OPG with 3-OMG ( Figure 1 ), it can be readily ascertained that their structures are highly similar except for the replacement of am ethyl group by ap ropargyl group,w hich is ac ommon strategy to introduce the alkyne group and maintain the original function, such as in propargylcholine [6b] and O-propargylpuromycin.
[6c]
Spontaneous Raman spectrum of 3-OPG is then characterized with asharp and strong peak at 2129 cm À1 in the cellsilent region (Figure 2a ,b lack), indicative of the Ramanactive mode of C Cs tretching. Negligible cellular background in 1800-2400 cm À1 is confirmed by both spontaneous Raman spectrum and SRS image at 2129 cm À1 of blank HeLa cells (Supporting Information, Figure S1 ). Intrinsic Raman peaks of glucose,s uch as those from CÀCa nd CÀOb ond vibrations,a re also observed in the fingerprint region from 1000-1800 cm À1 (Figure 2a ,black). Note that these peaks are not only much weaker than the alkyne peak but also overlapping with the cellular background (Figure 2a,r ed) , which makes label-free Raman imaging of glucose in cells rather challenging. [9] Thus,i ntroducing an exogenous alkyne tag not only promotes the sensitivity but also endows imaging specificity in the otherwise crowded cellular background without the need of spectral unmixing.
Theuptake of 3-OPG was then tested in mammalian cell cultures.Adistinct peak (2129 cm À1 )emerges after incubating HeLa cells with 25 mm 3-OPG for 4h (Figure 2a,red) , which exactly matches with that in the phosphate-buffereds aline (PBS) solution spectrum of 3-OPG,c onfirming cellular uptake of 3-OPG.N oc ytotoxicity of 3-OPG is observed from cell viability assays (Supporting Information, Figure S2 ). Cellular distribution of 3-OPG can be visualized with high sensitivity and speed by SRS imaging of the alkyne Raman peak at 2129 cm À1 in HeLa cells incubated with 8mm 3-OPG for 1hour (Figure 2b ). Thec orresponding off-resonance image at 2000 cm À1 confirms the background-free nature of SRS.A sar eference,S RS image at 1655 cm À1 shows cellular protein distribution by targeting at protein amide Iband.
To quantify the intracellular uptake level, we correlated SRS intensity at 2129 cm À1 with known concentrations of 3-OPG solutions under identical conditions,w hich gives ad etection sensitivity of 1.4 mm with 30 msa cquisition time per pixel and circa 26 sp er frame (Supporting Information, Figure S3 ). Forhigher signal-to-noise ratio and more accurate quantifications,w ec hose 25 mm 3-OPG as incubation concentration for further biochemistry characterizations.
To validate that 3-OPG is transported into cells through glucose transporters,s everal control experiments were performed. First, uptake of 3-OPG was competed using dglucose at different concentrations ( Figure 3) . As the concentration of d-glucose increases,c ellular uptake of 3-OPG decreases accordingly,r eaching 78 %w ith 10 mmd -glucose and 53 %w ith 50 mmd -glucose,c onsistent with the higher transporter affinity of d-glucose (Figure 3a-c) . In contrast, with 50 mml -glucose,w hich is not recognized by glucose transporters for its opposite chirality,3 -OPG uptake level is unaffected (Figure 3d) .
Four different transporter inhibition and stimulation assays were then conducted. Using RNAi nterference to suppress the expression of GLUT1 transporter,H eLa cells transfected with 10 nm GLUT1 siRNAfor 48 hshow amuch reduced uptake of 3-OPG (54 %) compared to the control groups (Figure 3e,f) . Moreover,H eLa cells incubated with 10 mm cytochalasin B, ap otent inhibitor of glucose carriers, display ad rastic reduction to 35 %i n3 -OPG uptake (Figure 3g,h) . Efflux experiments of 3-OPG-loaded HeLa cells were also performed with arapid decay after 30 min and the addition of cytochalasin Bsignificantly inhibits the efflux of 3-OPG (Supporting Information, Figure S4 ), indicating the transport of 3-OPG in both directions is carrier-mediated. We further studied the effect of insulin stimulation on 3-OPG uptake by GLUT4 in rat muscle cells.W ith 1 mgmL À1 insulin for 24 h, which stimulates GLUT4 translocation to plasma membrane,acirca 30 %increase in 3-OPG uptake is observed in fused L6 cells (Supporting Information, Figure S5 ), suggesting GLUT4-mediated uptake of 3-OPG.T aken together, these results further prove the glucose transporter dependence of 3-OPG uptake and its role as a d-glucose analogue to mammalian cells.
Uptake kinetics of 3-OPG were also examined (Supporting Information, Figures S6 and S7 ). At 37 8 8C, buildup of 3-OPG inside HeLa cells reaches ap lateau within 30 min, indicating fast uptake of 3-OPG at physiological temperature and allowing steady-state imaging.T his equilibrium time is consistent with the reported size and weight dependence of transport kinetics for different glucose analogues. [10] Lowering to room temperature slows down 3-OPG uptake,a s expected. Linear fitting of 3-OPG uptake at early times also reveals acirca threefold decrease in initial transport rate from 37 8 8Ctoroom temperature.Quantitatively,byplotting initial rates of 3-OPG uptake against different incubation concentrations (Supporting Information, Figure S7 ), its K m and V max parameters are extracted in HeLa cells where GLUT1 is the most abundant isoform. [11] Thef itted values of K m = 26 AE 4mm and V max = 0.71 AE 0.05 mm min À1 of 3-OPG uptake turn out to be very close to that for 3-OMG uptake by human GLUT1 expressed in Xenopus oocytes (K m = 13-20 mm and V max = 0.74 mm min À1 assuming 10 6 oocytesp er L). [12] Competition experiments using 3-OMG show am oderate reduction to 70 %i n3 -OPG uptake (Supporting Information, Figure S8 ), which is again in agreement with their similar K m .
Furthermore,i mportant insights can be gained by simultaneously imaging cellular uptake of 3-OPG and 2-NBDG by the same set of cells (Supporting Information, Figure S9 ). While 2-NBDG displays ah eterogeneous pattern with stronger signal enriched in cellular structures surrounding the nucleus,3 -OPG is distributed more homogeneously throughout the cells including inside the nucleus.S uch differential contrast between 3-OPG and 2-NBDG is likely due to non-specific retention of 2-NBDG in extra-nuclear organelles (such as endoplasmic reticulum) and its low permeability across nuclear membrane caused by the strong hydrophobicity and/or large size of the NBD fluorophores. [5] Hence we have obtained direct imaging evidence that 3-OPG could be amore truthful probe to report the genuine glucose uptake and distribution inside cells.
Tu mors are well known to have aberrant metabolism with upregulated glucose uptake.C ancer cells of different phenotypes also have varied glucose uptake levels,w hich could serve as am arker for tumor malignancya nd metastatic potential.
[2a] We thus compare glucose uptake activity between HeLa, ah uman cervical cancer cell line and U-87 MG,ahuman primary glioblastoma cell line,using 3-OPG as imaging probe (Supporting Information, Figure S10 ). As the highest-grade glioma (WHO grade IV), glioblastoma is the most aggressive form of malignant primary brain tumor. Incubated with 3-OPG,U-87 MG cells display amuch higher alkyne peak than that of HeLa cells in Raman spectra, suggesting am ore pronounced glucose uptake activity.S RS images further show the whole intracellular distribution of 3-OPG in both cancer cells.C onsistent with the spectroscopic results,U -87 MG cells indeed exhibit abrighter intracellular signal than HeLa cells,c onfirming much increased glucose uptake activity.Q uantitatively,3 -OPG uptake in U-87 MG cells is over 1.7 times higher than that of HeLa cells.Thus SRS imaging of 3-OPG uptake could be au seful technique to distinguish cancer cells with varied metabolic characteristics.
Uptake of 3-OPG is further visualized in mouse subcutaneous tumor xenograft model. Tu mor regions with distinct glucose uptake levels are observed (Figure 4) . In outer region of the tumor,c ells undergo fast proliferation and hence uptake glucose significantly (Figure 4a ). In contrast, toward the center of tumor, cells display as mall and broken morphology (as shown in the amide channel at 1655 cm À1 ), 
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Chemie suggesting necrosis and diminished cellular activity.I ndeed, little 3-OPG uptake is seen in the SRS image with asignal at least five times lower than that in the tumor-propagating region (Figure 4b ). Thei nterface between the two tumor regions can be clearly distinguished by highlighting the 3-OPG uptake contrast at the single cell level, providing useful microscopic insights (Figure 4c ). Necrosis is known to be ah istological hallmark of glioblastoma and an important predictor for tumor prognosis in clinical glioma diagnostics and staging. [13] We discover that the metabolic contrast from 3-OPG uptake is much more pronounced than the label-free images of endogenous lipid (at 2845 cm À1 )o rp rotein (at 1655 cm À1 ) distributions.Most notably,asmall population of tumor cells with high glucose uptake activity is identified within the region of diminished activity (Figure 4c,arrowhead) , reflecting cell-cell variation of metabolic status.T herefore,t his showcases the capability of vibrational imaging of glucose uptake activity using 3-OPG and provides opportunity for studying intratumoral heterogeneity in energy consumptions during brain tumor growth with superb contrast and cellular resolution.
Theb rain is the central control of activity in higher organisms and has ahigh energy demand. Fast and adequate glucose supply is critical for maintaining the neural activity. We therefore demonstrate imaging 3-OPG uptake in both in vitro neuron culture and ex vivo mouse brain tissue ( Figure 5 ). In cultured mouse primary hippocampal neurons, not only ahigh level of 3-OPG is imaged inside the soma, but also it can be seen clearly in the neuronal processes (Figure 5a ), reflecting energy need in axons and dendrites for neural signaling.I ntercellularly,s ignificant variation in 3-OPG uptake is observed among different neurons,with over 2 times difference from cells with low-glucose level to highglucose demanding cells (Figure 5a,a rrowhead) . This observation from the 3-OPG channel, which is absent from the corresponding protein amide image,indicates heterogeneous energy requirement at single neuron level. Going beyond the neuron cultures,3 -OPG uptake is also visualized in the hippocampus of mouse brain tissue slice cultured ex vivo. Pronounced signal is present in both the granule cell layer and nearby hilar region of dentate gyrus,which is known to exhibit high metabolic activity [14] (Figure 5b ). Thus,3 -OPG is generally applicable as av ibrational imaging probe for glucose transport in both tumor and brain study with subcellular resolution.
In summary,w ehave designed, synthesized, and characterized an ovel glucose analogue with an alkyne vibrational tag (3-OPG). By coupling SRS microscopy to the alkyne tag, we have demonstrated vibrational imaging of glucose uptake activity in living cells and tissues with high sensitivity, specificity,a nd biocompatibility.O ur method can differentiate cancer cells with varied metabolic activities and reveal heterogeneous glucose uptake patterns in tumor xenograft tissues as well as in neuronal culture and mouse brain tissues at cellular resolution. Previous studies have been reported on glucose sensing in blood and metabolic incorporation using isotope-labeled glucose for imaging downstream products with Raman techniques.
[15] However,t hey are either not in cellular environment or cannot visualize glucose uptake activity specifically.I fc ompared to the classic PET tracers, 3-OPG can be synthesized in ah ighly cost-effective way without special handling of radioactive materials and endows optical imaging with subcellular resolution. If compared to the bulky fluorescent glucose analogues,3 -OPG has am inor structural modification without adding as ignificant size and weight to glucose,r endering better affinity to glucose transporters,less non-specific interaction, and higher translocation efficiency (for example,c rossing the blood-brain barrier). With the use of near-infrared lasers for nonlinear excitation, SRS is capable of high-resolution and deep tissue imaging with minimal phototoxicity and essentially no photobleaching, [16] and has recently achieved video-rate imaging in live animals and humans with potential clinical applications. [17] We therefore expect that vibrational imaging of 3-OPG with SRS microscopy would become an attractive technique for studying glucose uptake activity at the cellular level, especially in brain and malignant tumors that are inherently in high demand of energy.
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